These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28731000)

  • 1. Appropriateness-based reimbursement of elective invasive coronary procedures in low- and middle-income countries: Preliminary assessment of feasibility in India.
    Karthikeyan G; Shirodkar U; Lochan MR; Birch S
    Natl Med J India; 2017; 30(1):11-14. PubMed ID: 28731000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme - A tertiary centre experience from Western India.
    Patil D; Lanjewar C; Vaggar G; Bhargava J; Sabnis G; Pahwa J; Phatarpekar A; Shah H; Kerkar P
    Indian Heart J; 2017; 69(5):600-606. PubMed ID: 29054183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Accessibility, Cost, and Quality of Elective Coronary Revascularization Between Veterans Affairs and Community Care Hospitals.
    Barnett PG; Hong JS; Carey E; Grunwald GK; Joynt Maddox K; Maddox TM
    JAMA Cardiol; 2018 Feb; 3(2):133-141. PubMed ID: 29299607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program.
    Bradley SM; Bohn CM; Malenka DJ; Graham MM; Bryson CL; McCabe JM; Curtis JP; Lambert-Kerzner A; Maynard C
    Circulation; 2015 Jul; 132(1):20-6. PubMed ID: 26022910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of health insurance benefit design on percutaneous coronary intervention use and inpatient costs among patients with acute myocardial infarction in Shanghai, China.
    Yuan S; Liu Y; Li N; Zhang Y; Zhang Z; Tao J; Shi L; Quan H; Lu M; Ma J
    Pharmacoeconomics; 2014 Mar; 32(3):265-75. PubMed ID: 23975740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of barriers and facilitators in the implementation of appropriate use criteria for elective percutaneous coronary interventions: a qualitative study.
    Lambert-Kerzner A; Maynard C; McCreight M; Ladebue A; Williams KM; Fehling KB; Bradley SM
    BMC Cardiovasc Disord; 2018 Aug; 18(1):164. PubMed ID: 30103677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.
    Hannan EL; Samadashvili Z; Cozzens K; Gesten F; Osinaga A; Fish DG; Donahue CL; Bass RJ; Walford G; Jacobs AK; Venditti FJ; Stamato NJ; Berger PB; Sharma S; King SB
    J Am Coll Cardiol; 2017 Mar; 69(10):1234-1242. PubMed ID: 28279289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing.
    Inohara T; Kohsaka S; Miyata H; Ueda I; Ishikawa S; Ohki T; Nishi Y; Hayashida K; Maekawa Y; Kawamura A; Higashi T; Fukuda K
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1000-9. PubMed ID: 25234672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of elective percutaneous coronary intervention in Malaysia: a multicentre cross-sectional costing study.
    Lee KY; Ong TK; Low EV; Liow SY; Anchah L; Hamzah S; Liew HB; Ali RM; Ismail O; Ahmad WAW; Said MA; Dahlui M
    BMJ Open; 2017 May; 7(5):e014307. PubMed ID: 28552843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.
    Thomas MP; Parzynski CS; Curtis JP; Seth M; Nallamothu BK; Chan PS; Spertus JA; Patel MR; Bradley SM; Gurm HS
    PLoS One; 2015; 10(9):e0138251. PubMed ID: 26379053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving from volume to value for revascularization in stable ischemic heart disease: A review.
    Gibbons RJ; Weintraub WS; Brindis RG
    Am Heart J; 2018 Oct; 204():178-185. PubMed ID: 30077336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost Savings Associated With Implementation of Peer-Reviewed Appropriate Use Criteria for Percutaneous Coronary Interventions.
    Puri P; Carroll J; Patterson B
    Am J Cardiol; 2016 Apr; 117(8):1289-93. PubMed ID: 26899491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.
    Desai NR; Bradley SM; Parzynski CS; Nallamothu BK; Chan PS; Spertus JA; Patel MR; Ader J; Soufer A; Krumholz HM; Curtis JP
    JAMA; 2015 Nov; 314(19):2045-53. PubMed ID: 26551163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions.
    Chan PS; Rao SV; Bhatt DL; Rumsfeld JS; Gurm HS; Nallamothu BK; Cavender MA; Kennedy KF; Spertus JA
    J Am Coll Cardiol; 2013 Dec; 62(24):2274-81. PubMed ID: 24055743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.
    Hess PL; Kini V; Liu W; Roldan P; Autruong P; Grunwald GK; O'Donnell C; Doll JA; Ho PM; Bradley SM
    JAMA Netw Open; 2020 Apr; 3(4):e203144. PubMed ID: 32315067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of private insurance incentive policy reforms on trends in coronary revascularisation procedures in the private and public health sectors in Western Australia: a cohort study.
    Trafalski S; Briffa T; Hung J; Moorin RE; Sanfilippo F; Preen DB; Einarsdóttir K
    BMC Health Serv Res; 2013 Jul; 13():280. PubMed ID: 23870450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of policy alterations on elective percutaneous coronary interventions in Japan.
    Morishita T; Takada D; Shin JH; Kunisawa S; Fushimi K; Imanaka Y
    Heart; 2023 Mar; 109(8):612-618. PubMed ID: 36627183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.
    Chen SH; Ho KK; Gannon SA; Thyagarajan B; Chakrabarti AK; Potter BJ; Singla A; Piccirillo BJ; Meduri CU; Cutlip DE
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):E74-9. PubMed ID: 26699241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery.
    Wennberg DE; Lucas FL; Siewers AE; Kellett MA; Malenka DJ
    JAMA; 2004 Oct; 292(16):1961-8. PubMed ID: 15507581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.